<DOC>
	<DOCNO>NCT01355822</DOCNO>
	<brief_summary>Pregnancies result IUGR also preeclampsia strongly associate typical underlying placental pathology reveal small placenta maldevelopment decidual blood vessel , suggest under-perfusion maternal circulation . Since nitric oxide ( NO ) donor improve decrease uteroplacental perfusion without negative effect fetal circulation , may prevent negative pregnancy outcomes patient risk . The aim study evaluate effectiveness long-lasting NO donor pentarythrithyltetranitrate ( PETN ) reduce likelihood adverse pregnancy outcome ( intrauterine growth retardation / IUGR , perinatal death , placental abruption , preterm delivery ) woman recognize risk outcome abnormal uterine flow mid gestation .</brief_summary>
	<brief_title>Impact NO-donor Pentaerythrithyltetrantrate Perinatal Outcome High-risk Pregnancies</brief_title>
	<detailed_description />
	<criteria>pregnant woman 190 236 week gestation abnormal uterine Doppler define bilateral notching , unilateral notching increase impedance mean resistance index ( RI ) &gt; 0.65 mean RI &gt; 0.7 without notch time enrollement inform consent multiple gestation document chromosomal major fetal abnormality rupture membrane and/or clinical chorioamnionitis time enrolment maternal disease define contraindication intake PETN</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>abortion</keyword>
	<keyword>perinatal death</keyword>
	<keyword>IUGR</keyword>
	<keyword>preterm birth</keyword>
	<keyword>placental abruption</keyword>
	<keyword>preeclampsia</keyword>
</DOC>